DE69927128T2 - Verwendung von topisch applizierbaren Gerinnungsmaterial - Google Patents

Verwendung von topisch applizierbaren Gerinnungsmaterial Download PDF

Info

Publication number
DE69927128T2
DE69927128T2 DE69927128T DE69927128T DE69927128T2 DE 69927128 T2 DE69927128 T2 DE 69927128T2 DE 69927128 T DE69927128 T DE 69927128T DE 69927128 T DE69927128 T DE 69927128T DE 69927128 T2 DE69927128 T2 DE 69927128T2
Authority
DE
Germany
Prior art keywords
coagulation material
topically applicable
topically
applicable
coagulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927128T
Other languages
English (en)
Other versions
DE69927128D1 (de
Inventor
James Franklin Drake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEMARREST Inc
Original Assignee
HEMARREST Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26680154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69927128(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by HEMARREST Inc filed Critical HEMARREST Inc
Application granted granted Critical
Publication of DE69927128D1 publication Critical patent/DE69927128D1/de
Publication of DE69927128T2 publication Critical patent/DE69927128T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
DE69927128T 1999-02-08 1999-10-22 Verwendung von topisch applizierbaren Gerinnungsmaterial Expired - Lifetime DE69927128T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/246,231 US6060461A (en) 1999-02-08 1999-02-08 Topically applied clotting material
PCT/US2000/005220 WO2001064148A1 (en) 1999-02-08 2000-02-29 Topically applied clotting material

Publications (2)

Publication Number Publication Date
DE69927128D1 DE69927128D1 (de) 2005-10-13
DE69927128T2 true DE69927128T2 (de) 2006-06-14

Family

ID=26680154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927128T Expired - Lifetime DE69927128T2 (de) 1999-02-08 1999-10-22 Verwendung von topisch applizierbaren Gerinnungsmaterial

Country Status (7)

Country Link
US (1) US6060461A (de)
EP (1) EP1025868B1 (de)
JP (1) JP5005145B2 (de)
AU (2) AU2000237124B2 (de)
CA (1) CA2399870C (de)
DE (1) DE69927128T2 (de)
WO (1) WO2001064148A1 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
CA2350628A1 (en) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
US6472162B1 (en) * 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
US6502579B2 (en) * 2000-01-19 2003-01-07 William P. Young Laser onychectomy by resection of the redundant epithelium of the ungual crest
US6890342B2 (en) 2000-08-02 2005-05-10 Loma Linda University Method and apparatus for closing vascular puncture using hemostatic material
EP1409028A4 (de) * 2000-10-13 2005-07-20 On Site Gas Systems Inc Verband unter verwendung von molekularsieben
CA2446374C (en) * 2001-05-09 2012-09-11 Biointeractions Ltd. Surgical wound closure system
IL159156A0 (en) * 2001-06-22 2004-06-01 Millard Marsden Mershon A gel forming composition containing a polyacrylic acid
US20030093114A1 (en) 2001-11-13 2003-05-15 Melvin Levinson Method for effecting hemostasis
US7101862B2 (en) * 2001-12-31 2006-09-05 Area Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
US6992233B2 (en) * 2002-05-31 2006-01-31 Medafor, Inc. Material delivery system
JP4544991B2 (ja) * 2002-06-14 2010-09-15 ローマ リンダ ユニヴァーシティ メディカル センター 血管の創傷をふさぐ装置および方法
EP1638491A4 (de) * 2003-06-16 2008-05-28 Univ Loma Linda Med Ablegbares multifunktionales hämostasemittel
EP1643934A4 (de) * 2003-06-16 2008-05-28 Univ Loma Linda Med Ablegbares hämostatisches mittel
CA2535452C (en) 2003-08-14 2013-04-02 Loma Linda University Medical Center Vascular wound closure device
EP1663090A4 (de) 2003-09-12 2010-07-21 Z Medica Corp Calcium-zeolit-hämostasemittel
DE602004030264D1 (de) * 2003-09-12 2011-01-05 Z Medica Corp Teilweise hydriertes hämostatisches mittel
ES2384519T3 (es) * 2004-02-23 2012-07-06 Loma Linda University Medical Center Agente hemostático para uso tópico e interno
WO2006012541A2 (en) * 2004-07-22 2006-02-02 Henry Eisenson Compositions and methods for treating excessive bleeding
US20060141060A1 (en) * 2004-12-27 2006-06-29 Z-Medica, Llc Molecular sieve materials having increased particle size for the formation of blood clots
US20060178609A1 (en) 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
WO2006088912A2 (en) 2005-02-15 2006-08-24 Virginia Commonwealth University Mineral technologies (mt) for acute hemostasis and for the treatment of acute wounds and chronic ulcers
US20060211971A1 (en) * 2005-03-16 2006-09-21 Z-Medica, Llc Pillow for the delivery of blood clotting materials to a wound site
US9326995B2 (en) 2005-04-04 2016-05-03 The Regents Of The University Of California Oxides for wound healing and body repair
US20060282046A1 (en) * 2005-04-13 2006-12-14 Horn Jeffrey L Device and method for subcutaneous delivery of blood clotting agent
US7517355B2 (en) * 2005-09-08 2009-04-14 Medafor, Incorporated Method of supporting and/or applying particulate materials
WO2007033135A2 (en) * 2005-09-13 2007-03-22 Imed Scientific Corporation Process for manufacturing hemostatic agents and their uses
ATE499882T1 (de) * 2005-10-05 2011-03-15 Univ Loma Linda Med Gefässwundverschluss-vorrichtung
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070142783A1 (en) * 2005-12-16 2007-06-21 Huey Raymond J Devices and methods for promoting the formation of blood clots at dialysis access sites
US20070154510A1 (en) * 2005-12-30 2007-07-05 Wilcher Steve A Adsorbent-Containing Hemostatic Devices
US20070154509A1 (en) * 2005-12-30 2007-07-05 Wilcher Steve A Adsorbent-Containing Hemostatic Devices
US9474652B2 (en) * 2006-01-09 2016-10-25 Jack Mentkow Hemostatic agent delivery system
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US8938898B2 (en) 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US20070276308A1 (en) * 2006-05-26 2007-11-29 Huey Raymond J Hemostatic agents and devices for the delivery thereof
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US20080063697A1 (en) * 2006-09-08 2008-03-13 Bedard Robert L Use of Unactivated Calcium Exchanged Zeolites in Hemostatic Devices and Products
US9198995B2 (en) 2006-09-20 2015-12-01 Ore-Medix Llc Conformable structured therapeutic dressing
US8623842B2 (en) * 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
US8414550B2 (en) * 2006-09-29 2013-04-09 Lexion Medical, Llc System and method to vent gas from a body cavity
US20080145455A1 (en) * 2006-12-13 2008-06-19 Bedard Robert L Combination of Inorganic Hemostatic Agents with Other Hemostatic Agents
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
US20090047366A1 (en) * 2007-08-15 2009-02-19 Bedard Robert L Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants
WO2009032884A1 (en) * 2007-09-05 2009-03-12 Z-Medica Corporation Wound healing with zeolite-based hemostatic devices
US8883194B2 (en) * 2007-11-09 2014-11-11 Honeywell International, Inc. Adsorbent-containing hemostatic devices
CN101455857B (zh) 2007-12-11 2014-03-12 纪欣 生物相容性变性淀粉海绵
US20090175926A1 (en) * 2008-01-08 2009-07-09 Adams Theodore P Topical burn treatment
CN104888263B (zh) 2008-01-14 2018-11-30 北京环球利康科技有限公司 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
CN101497670B (zh) * 2008-01-29 2012-04-25 纪欣 生物相容性预糊化的变性淀粉及其制备方法
US8585646B2 (en) 2008-03-03 2013-11-19 Lexion Medical, Llc System and method to vent gas from a body cavity
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US8795718B2 (en) * 2008-05-22 2014-08-05 Honeywell International, Inc. Functional nano-layered hemostatic material/device
JP6134933B2 (ja) * 2009-01-27 2017-05-31 レッドドレス リミテッド 創傷包帯剤、これを作製するための方法及び器具及びその保存及び使用
WO2010102283A2 (en) * 2009-03-06 2010-09-10 Jack Mentkow Hemostatic agent composition, delivery system and method
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
CN102844053B (zh) 2009-11-25 2015-08-05 洛马林达大学医学中心 基于壳聚糖的止血织物
BR112012012997B8 (pt) 2009-12-04 2021-05-25 Magle Ab microesfera biodegradável, material para utilização em conexão com o tratamento de feridas compreendendo microesferas, curativo de ferida e método para cultura de células in vitro
KR101003331B1 (ko) * 2010-05-11 2010-12-23 조강선 피부 충전제 조성물
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
CN102178691B (zh) * 2011-05-05 2012-07-18 王美岭 一种淀粉止血剂及制备方法
CA3104937C (en) 2011-11-01 2023-10-24 Abyrx, Inc. Compositions and methods for hemostasis
KR102189877B1 (ko) 2012-06-22 2020-12-14 지-메디카 엘엘씨 지혈 장치
US9339638B2 (en) * 2012-08-08 2016-05-17 Healthpartners Research & Education Antibiotic delivery system and method
DE102013211316A1 (de) 2013-06-17 2014-12-18 Aesculap Ag Hämostyptikum
EP2857350A1 (de) * 2013-09-10 2015-04-08 ESPCI Innov Verwendung von Nanopartikeln zum Verkleben von Gels
EP4159248A1 (de) * 2013-12-10 2023-04-05 Institut National de la Santé et de la Recherche Médicale (INSERM) Verfahren zum verkleben von gewebeoberflächen und materialien und biomedizinische verwendungen davon
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
WO2016100861A1 (en) 2014-12-19 2016-06-23 Baxter International, Inc. Flowable hemostatic composition
US11213423B2 (en) 2015-03-31 2022-01-04 Zoll Circulation, Inc. Proximal mounting of temperature sensor in intravascular temperature management catheter
JP6759335B2 (ja) 2015-05-06 2020-09-23 ジャイラス・エーシーエムアイ・インコーポレーテッド カルボキシメチルキトサンスポンジ配合物
CN104906629B (zh) * 2015-05-15 2018-03-30 成都大学 一种介孔生物活性玻璃/马勃复合材料及其制备与应用
CN206214465U (zh) * 2015-05-29 2017-06-06 杭州弘复医疗科技有限公司 皮肤或创面复合敷料及其套件
CN105233326A (zh) * 2015-11-09 2016-01-13 史跃 一种可吸收的微孔真空多聚糖微粒球的制备方法与用途
CN105688265A (zh) * 2016-01-22 2016-06-22 青岛中腾生物技术有限公司 一种可吸收止血材料及其制备方法和用途
CN106377792B (zh) * 2016-09-29 2019-12-03 江苏华能药业有限公司 复合微孔交联淀粉止血粉
CN106730047B (zh) * 2016-12-07 2018-05-11 成都迪康中科生物医学材料有限公司 一种止血防粘连膜及其制备方法
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
EP3681950A4 (de) 2017-09-12 2021-06-16 Shilpa Medicare Limited Tranexamsäurespray für kniearthroplastik
DE102018000009A1 (de) 2018-01-04 2019-03-07 PlantTec Medical GmbH Arzneimittel
CN113423369B (zh) 2019-02-15 2023-08-18 巴德股份有限公司 止血活检道制品
KR20210052099A (ko) 2019-10-31 2021-05-10 주식회사 삼양바이오팜 분말형 지혈제 조성물 및 이의 제조 방법
CA3176918A1 (en) * 2020-04-17 2021-10-21 Boston Scientific Scimed, Inc. Hemostatic compositions and related methods
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
FR2339805A1 (fr) * 1976-01-28 1977-08-26 Torossian Fernand Procede et dispositifs pour supprimer des fuites de fluides dans une cavite
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
JPS55148209A (en) * 1979-04-27 1980-11-18 Kuraray Co Ltd Hollow ethylene-vinyl alcohol membrane and its production
DE3028213C2 (de) * 1980-07-25 1990-12-06 Akzo Gmbh, 5600 Wuppertal Verfahren zur Herstellung einer Ultrafiltrationsmembran aus Polyamid und daraus hergestellte Membran
US4615880A (en) * 1980-07-30 1986-10-07 Ceskoslovenska Akademie Ved Of Prague Dressing for wounds and the method for manufacturing thereof
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4373519A (en) * 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
EP0302536B1 (de) * 1982-04-22 1992-11-19 E.R. Squibb & Sons, Inc. Granulate zur Verwendung bei der Behandlung von Wunden
NZ203706A (en) * 1982-04-22 1986-03-14 Squibb & Sons Inc Occlusive multi-layer wound dressing and hydrocolloidal granules for wound treatment
US4783448A (en) * 1983-06-07 1988-11-08 Perstorp Ab Method for cleansing an infected sore
FR2555589B1 (fr) * 1983-11-30 1986-05-16 Choay Sa Nouveaux derives du dextrane a activites anticoagulante en anti-inflammatoire, leur procede de preparation et utilisation de ces derives en tant qu'anticoagulants et en tant que substituts du plasma sanguin
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
HU193372B (en) * 1985-05-21 1987-09-28 Biogal Gyogyszergyar Process for the purification of a dextrane bead polymer of stereoscopic mesh structure suitable for pharmaceutical purposes
SE457770B (sv) * 1985-05-23 1989-01-30 Pharmacia Ab Foerfarande foer att stabilisera en vattenhaltig dispersion av vattenabasorberade partiklar
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US5348941A (en) * 1992-04-01 1994-09-20 Merck & Co., Inc. Stabilizers for fibroblast growth factors
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
JPH08502534A (ja) * 1992-10-21 1996-03-19 コーネル リサーチ ファウンデーション、インコーポレーテッド 多孔物質の細孔サイズ選択的修飾法
US5718969A (en) * 1993-08-25 1998-02-17 Fmc Corporation Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation
US5502042A (en) * 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US5529929A (en) * 1995-06-07 1996-06-25 Seprachem, Inc. Optical resolution of alkyl 1,4-benzodioxan-2-carboxylates using esterase from serratia marcescens
US5700902A (en) * 1995-07-27 1997-12-23 Circe Biomedical, Inc. Block copolymers
US5836970A (en) * 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
US5817381A (en) * 1996-11-13 1998-10-06 Agricultural Utilization Research Institute Cellulose fiber based compositions and film and the process for their manufacture
US5977428A (en) * 1996-12-20 1999-11-02 Procyte Corporation Absorbent hydrogel particles and use thereof in wound dressings
GB2335921B (en) * 1997-01-30 2000-08-02 Alpenstock Holdings Ltd Microdispersed polyanhydroglucuronic acid and salts thereof

Also Published As

Publication number Publication date
EP1025868B1 (de) 2005-09-07
AU2000237124B2 (en) 2004-09-30
US6060461A (en) 2000-05-09
CA2399870A1 (en) 2001-09-07
JP2004530448A (ja) 2004-10-07
WO2001064148A1 (en) 2001-09-07
CA2399870C (en) 2009-05-26
DE69927128D1 (de) 2005-10-13
AU3712400A (en) 2001-09-12
EP1025868A1 (de) 2000-08-09
JP5005145B2 (ja) 2012-08-22

Similar Documents

Publication Publication Date Title
DE69927128T2 (de) Verwendung von topisch applizierbaren Gerinnungsmaterial
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE60033896D1 (de) Unterscheidung von Modulationsarten
DE59905858D1 (de) Verwendung von pit-emulsionen
ATE240913T1 (de) Herstellung von betonbeschleuniger
DE60021070D1 (de) Kodierung von mikroträgern
DE69903655D1 (de) Verwendung von menthyl-2-pyrrolidon-5-carboxylat zur insektenabwehr
DE59903869D1 (de) Verwendung von nanoskaligen sterolen und sterolestern
ATE264069T1 (de) Verstärkung von nahrungsmitteln
DE60021903D1 (de) Verwendung von zusammensetzungen zur textilpflege
DE69907146D1 (de) Direkte oxidation von cycloalkanen
DE50003729D1 (de) Verwendung von emulsionen als imprägnier- und avivagemittel
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
DE60008353D1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
DE60000343D1 (de) Stabilisierung von isothiazolonen
DE69922558D1 (de) Herstellung von Aluminiumoxid
DE50009938D1 (de) Verwendung von nanoskaligen wachsen
ATE243197T1 (de) Kristallformen von osanetant
DE69927626D1 (de) Ausführung von Permutationen
ATE433323T1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
DE50006852D1 (de) Verwendung von nanoskaligen deodorantien
DE60007360D1 (de) Amorphe modifikation von torasemid
DE60007111D1 (de) Herstellung von ausgewählten fluorolefinen
DE60022125D1 (de) Tiefstkühlen von Waren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1025868

Country of ref document: EP

Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LU